Abrinica, Clyde .

HRN: 27-22-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/30/2025
10/14/2025
IV
92mg As Loading Dose; 70mg As Maintenance
Q24H
Hospital Acquired Pneumonia; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: